Capital Expenditure for Production Rationalization and Equipment Renewal
First written in FY2016. 9 of 11 entries say "Advanced", first in FY2018. Latest entry: FY2025.
9 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「Capital expenditures for the fiscal year amounted to ¥698.350 million.」
Capital expenditures for production rationalization and equipment upgrades increased from ¥344.331 million in the previous fiscal year to ¥698.350 million. - FY2025-H1AdvancedAnnual report
「Growth investment in the existing multipurpose plant was carried out during the fiscal year to expand production capacity.」
Investment to expand production capacity at the existing multipurpose plant progressed from the previously disclosed decision and planning stages to the execution stage. - FY2024AdvancedAnnual report
「In the chemical industrial products business, the Company has made the capital expenditures necessary to rationalize production and upgrade equipment. Capital expenditures for the fiscal year amounted to ¥344.331 million.」
Annual capital expenditures for production rationalization and equipment upgrades amounted to ¥344.331 million. In addition, renovation of the existing multipurpose plant, with a total cost of ¥560 million, was scheduled to begin in March 2025 and be completed in June 2025. - FY2024-Q2AdvancedAnnual report
「Against this backdrop, to achieve the targets set out in the medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026,” ACCEL2026—“Driving innovation powerfully and accelerating growth”—the Group is investing in equipment for its existing multi-purpose plant to increase production capacity while further expanding contract-synthesized products, promoting new product development, and pursuing market expansion.」
The project has progressed from the decision to invest in the existing multipurpose plant in the previous quarter to the stage of actually moving forward with the investment. - FY2024-Q1AdvancedAnnual report
「Against this backdrop, to achieve the targets set out in the medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026,” ACCEL2026—“Driving innovation powerfully and accelerating growth”—the Group decided to invest in equipment for its existing multi-purpose plant to increase production capacity while further expanding contract-synthesized products, promoting new product development, and pursuing market expansion using its proprietary synthesis technologies.」
The Company reported concrete progress on capital expenditures for production rationalization and equipment upgrades, with a decision to invest in an existing multipurpose plant to expand production capacity. - FY2023AdvancedAnnual report
「Capital expenditures for the fiscal year amounted to ¥313.545 million.」
Capital expenditures for the fiscal year amounted to ¥313.545 million. The Company also disclosed a plan to invest a total of ¥560 million in manufacturing equipment at the Kawaguchi Plant, with work scheduled to begin in March 2025 and be completed in June of the same year. - FY2022AdvancedAnnual report
「In the chemical industrial products business, the Company has made the capital expenditures necessary to rationalize production and upgrade equipment. Capital expenditures for the fiscal year amounted to ¥381.966 million.」
Annual capital expenditures for production rationalization and equipment upgrades amounted to ¥381.966 million, up from ¥261.860 million in the previous fiscal year. - FY2021Decrease in annual capital expendituresAnnual report
「Capital expenditures for the fiscal year amounted to ¥261.860 million.」
Capital expenditures for production rationalization and equipment upgrades continued, but annual capital expenditures amounted to ¥261.860 million, down from ¥779.542 million in the previous fiscal year. - FY2019AdvancedAnnual report
「Capital investment for the current consolidated fiscal year amounted to ¥779.542 million.」
Capital investment for production rationalization and equipment upgrades continued, increasing from ¥597.852 million in the previous fiscal year to ¥779.542 million. - FY2018AdvancedAnnual report
「In the chemical industrial products business, the company is making the capital investments necessary to rationalize production and upgrade equipment. Capital investment for the current consolidated fiscal year amounted to ¥597.852 million.」
Capital investment for production rationalization and equipment upgrades continued, with full-year capital investment totaling ¥597.852 million. - FY2016First statedAnnual report
「The chemical industrial chemicals business is making the capital investments necessary to rationalize production and renew equipment. Capital expenditure for the consolidated fiscal year was ¥290,010 thousand.」
Annual capital expenditure of ¥290,010 thousand for production rationalization and equipment renewal was identified as a separate theme for the first time.